Publication: The status of pharmacometrics in pregnancy: Highlights from the 3rd American conference on pharmacometrics
Issued Date
2012-12-01
Resource Type
ISSN
13652125
03065251
03065251
Other identifier(s)
2-s2.0-84869058991
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
British Journal of Clinical Pharmacology. Vol.74, No.6 (2012), 932-939
Suggested Citation
J. G Coen van Hasselt, Marilee A. Andrew, Mary F. Hebert, Joel Tarning, Paolo Vicini, Donald R. Mattison The status of pharmacometrics in pregnancy: Highlights from the 3rd American conference on pharmacometrics. British Journal of Clinical Pharmacology. Vol.74, No.6 (2012), 932-939. doi:10.1111/j.1365-2125.2012.04280.x Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/14487
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The status of pharmacometrics in pregnancy: Highlights from the 3rd American conference on pharmacometrics
Abstract
Physiological changes during pregnancy may alter drug pharmacokinetics. Therefore, mechanistic understanding of these changes and, ultimately, clinical studies in pregnant women are necessary to determine if and how dosing regimens should be adjusted. Because of the typically limited number of patients who can be recruited in this patient group, efficient design and analysis of these studies is of special relevance. This paper is a summary of a conference session organized at the American Conference of Pharmacometrics in April 2011, around the topic of applying pharmacometric methodology to this important problem. The discussion included both design and analysis of clinical studies during pregnancy and in silico predictions. An overview of different pharmacometric methods relevant to this subject was given. The impact of pharmacometrics was illustrated using a range of case examples of studies around pregnancy. © 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.